StreetInsider.com News Articles

Hexcel Corp. (HXL) PT Lowered to $117 at UBS

Fri, 23 Oct 2026 09:40:29 -0400

UBS analyst Gavin Parsons lowered the price target on Hexcel Corp. (NYSE: HXL) to $117.00 (from $123.00) while maintaining a Buy rating.

Hexcel Corp. (HXL) PT Lowered to $100 at RBC Capital

Fri, 23 Oct 2026 08:28:42 -0400

RBC Capital analyst Ken Herbert lowered the price target on Hexcel Corp. (NYSE: HXL) to $100.00 (from $105.00) while maintaining a Outperform rating.

Hexcel Corp. (HXL) PT Lowered to $92 at Morgan Stanley

Fri, 23 Oct 2026 05:58:16 -0400

Morgan Stanley analyst Kristine Liwag lowered the price target on Hexcel Corp. (NYSE: HXL) to $92.00 (from $97.00) while maintaining a Equalweight rating.

The analyst comments "We remain constructive on HXL's long-term growth and FCF opportunity, but near-term margin pressures and OEM execution risks warrant caution. We reiterate our Equal-weight rating and lower our PT to $92 from $97, reflecting lower earnings estimates."

Hexcel Corp. (HXL) PT Lowered to $92 at Morgan Stanley

Fri, 23 Oct 2026 05:58:16 -0400

Morgan Stanley analyst Kristine Liwag lowered the price target on Hexcel Corp. (NYSE: HXL) to $92.00 (from $97.00) while maintaining a Equalweight rating.

Hexcel falls on revenue miss and weak guidance

Wed, 21 Oct 2026 17:24:56 -0400

Investing.com -- Hexcel Corporation (NYSE:HXL) reported third quarter results that missed revenue expectations and reaffirmed guidance below analyst estimates, sending shares down over 8% in after-hours trading Wednesday.

The advanced composites manufacturer posted adjusted earnings per share of $0.50, narrowly beating the analyst consensus of $0.49. However, revenue of $496.4 million fell short of the $501.84 million estimate and represented an 8.8% increase from $456.2 million in the same quarter last year.

The company reaffirmed its full-year 2026 guidance, projecting adjusted EPS of $2.30 to $2.40 and revenue of $2.025 billion to $2.125 billion. The midpoint of the EPS

Hexcel falls on revenue miss and weak guidance

Wed, 21 Oct 2026 17:24:56 -0400

The company reaffirmed its full-year 2026 guidance, projecting adjusted EPS of $2.30 to $2.40 and revenue of $2.025 billion to $2.125 billion. The midpoint of the EPS

Form 10-Q HEXCEL CORP /DE/ For: Sep 30

Wed, 21 Oct 2026 16:36:00 -0400

si-local-file:///var/storage/secattach/20261021/27216973.html

Form 8-K HEXCEL CORP /DE/ For: Oct 21

Wed, 21 Oct 2026 16:25:00 -0400

si-local-file:///var/storage/secattach/20261021/27216792.html

Hexcel Corp. (HXL) Tops Q3 EPS by 1c; offers guidance

Wed, 21 Oct 2026 16:16:23 -0400

Hexcel Corp. (NYSE: HXL) reported Q3 EPS of $0.50, $0.01 better than the analyst estimate of $0.49. Revenue for the quarter came in at $496.4 million versus the consensus estimate of $501.84 million.

GUIDANCE:

Hexcel Corp. sees FY2026 EPS of $2.30-$2.40, versus the consensus of $2.40. Hexcel Corp. sees FY2026 revenue of $2.025-2.125 billion, versus the consensus of $2.094 billion.

For earnings history and earnings-related data on Hexcel Corp. (HXL) click here.

Hexcel Corp. (HXL) Tops Q3 EPS by 1c; offers guidance

Wed, 21 Oct 2026 16:16:23 -0400

Hexcel Corp. (NYSE: HXL) reported Q3 EPS of $0.50, $0.01 better than the analyst estimate of $0.49. Revenue for the quarter came in at $496.4 million versus the consensus estimate of $501.84 million.

GUIDANCE:

Hexcel Corp. sees FY2026 EPS of $2.30-$2.40, versus the consensus of $2.40. Hexcel Corp. sees FY2026 revenue of $2.025-2.125 billion, versus the consensus of $2.094 billion.

For earnings history and earnings-related data on Hexcel Corp. (HXL) click here.

Hexcel Declares Quarterly Dividend

Wed, 21 Oct 2026 16:16:00 -0400

STAMFORD, Conn.--(BUSINESS WIRE)-- Hexcel Corporation (NYSE: HXL) announced today that the Company’s Board of Directors has declared a regular quarterly cash dividend of $0.18 per share on the common stock of Hexcel, payable to stockholders of record as of November 2, 2026, with a payment date of November 9, 2026.

About Hexcel
Hexcel Corporation is a global leader in advanced lightweight composites technology. We provide innovative, high-performance material solutions that are lighter, stronger, and tougher, shaping a world that moves farther, smarter, and more efficiently. Our broad and unrivaled product range includes carbon fiber,

Hexcel Declares Quarterly Dividend

Wed, 21 Oct 2026 16:16:00 -0400

Hexcel Reports 2026 Third Quarter Results

Wed, 21 Oct 2026 16:15:00 -0400

STAMFORD, Conn.--(BUSINESS WIRE)-- Hexcel Corporation (NYSE: HXL):

Q3 2026 Sales were $496 million, an 8.8% increase compared to Q3 2025 sales of $456 million (9.2% increase in constant currency).
Q3 2026 GAAP diluted EPS of $0.50 compared to Q3 2025 GAAP diluted EPS of $0.26.
Q3 2026 adjusted diluted EPS of $0.50, compared to Q3 2025 adjusted diluted EPS of $0.37.
2026 guidance unchanged.
Share repurchase authorization increased to $750 million.

See Table C for reconciliation of GAAP and non-GAAP operating income, net income, earnings per share and operating cash flow to free cash flow. Free cash flow is cash from operations

Hexcel Reports 2026 Third Quarter Results

Wed, 21 Oct 2026 16:15:00 -0400

STAMFORD, Conn.--(BUSINESS WIRE)-- Hexcel Corporation (NYSE: HXL):

Q3 2026 Sales were $496 million, an 8.8% increase compared to Q3 2025 sales of $456 million (9.2% increase in constant currency).

Q3 2026 GAAP diluted EPS of $0.50 compared to Q3 2025 GAAP diluted EPS of $0.26.

Q3 2026 adjusted diluted EPS of $0.50, compared to Q3 2025 adjusted diluted EPS of $0.37.

2026 guidance unchanged.

Share repurchase authorization increased to $750 million.

See Table C for reconciliation of GAAP and non-GAAP operating income, net income, earnings per share and operating cash flow to free cash flow. Free cash flow is cash from operations

Hexcel Corp. (HXL) PT Lowered to $97 at Morgan Stanley

Mon, 19 Oct 2026 08:31:58 -0400
Morgan Stanley analyst Kristine Liwag lowered the price target on Hexcel Corp. (NYSE: HXL) to $97.00 (from $110.00) while maintaining a Equalweight rating.

Hexcel Corp. (HXL) PT Lowered to $105 at RBC Capital

Thu, 15 Oct 2026 09:14:19 -0400
RBC Capital analyst Ken Herbert lowered the price target on Hexcel Corp. (NYSE: HXL) to $105.00 (from $115.00) while maintaining a Outperform rating.

Seaport Global Securities Upgrades Hexcel Corp. (HXL) to Buy

Mon, 12 Oct 2026 02:16:19 -0400

Seaport Global Securities analyst Richard Safran upgraded Hexcel Corp. (NYSE: HXL) from Neutral to Buy with a price target of $104.00.
The analyst comments: “What's changed is that: 1) we recently had a chance to speak with CFO, Jamie Coogan; 2) we think recent A&D selling is overdone and provides a good entry point; and 3) we think Defense demand contributes to above consensus estimates after 2027. In this note, we discuss: our upgrade rationale, takeaways from our conversation with CFO Coogan, what's holding investors back, and what gets the stock to the next level.
We think current valuation implies too much

Seaport Global Securities Upgrades Hexcel Corp. (HXL) to Buy

Mon, 12 Oct 2026 02:16:19 -0400

Seaport Global Securities analyst Richard Safran upgraded Hexcel Corp. (NYSE: HXL) from Neutral to Buy with a price target of $104.00.
The analyst comments: “What's changed is that: 1) we recently had a chance to speak with CFO, Jamie Coogan; 2) we think recent A&D selling is overdone and provides a good entry point; and 3) we think Defense demand contributes to above consensus estimates after 2027. In this note, we discuss: our upgrade rationale, takeaways from our conversation with CFO Coogan, what's holding investors back, and what gets the stock to the next level.
We think current valuation implies too much

Hexcel Corp. (HXL) PT Lowered to $90 at TD Cowen

Fri, 09 Oct 2026 07:42:18 -0400
TD Cowen analyst Gautam Khanna lowered the price target on Hexcel Corp. (NYSE: HXL) to $90.00 (from $115.00) while maintaining a rating.

Form 4 HEXCEL CORP /DE/ For: Oct 02 Filed by: Li David H

Mon, 05 Oct 2026 18:00:00 -0400
si-local-file:///var/storage/secattach/20261005/27150226.html

Form 4 HEXCEL CORP /DE/ For: Oct 02 Filed by: Hubbard Patricia

Mon, 05 Oct 2026 18:00:00 -0400
si-local-file:///var/storage/secattach/20261005/27150224.html

Hexcel Schedules Third Quarter 2026 Earnings Release and Conference Call

Thu, 01 Oct 2026 08:30:00 -0400

STAMFORD, Conn.--(BUSINESS WIRE)-- Hexcel Corporation (NYSE: HXL) announced today that it will report financial results for its third quarter of 2026 on Wednesday, October 21 after the market close.
The company will host a webcast and conference call to discuss highlights of its financial results on Thursday, October 22 at 9:30 a.m. ET. The call will be hosted by Chairman, CEO and President Tom Gentile and Chief Financial Officer Jamie Coogan.
The event will be webcast via the Investor Relations webpage at www.Hexcel.com. The event can also be accessed by dialing

Hexcel Schedules Third Quarter 2026 Earnings Release and Conference Call

Thu, 01 Oct 2026 08:30:00 -0400

STAMFORD, Conn.--(BUSINESS WIRE)-- Hexcel Corporation (NYSE: HXL) announced today that it will report financial results for its third quarter of 2026 on Wednesday, October 21 after the market close.
The company will host a webcast and conference call to discuss highlights of its financial results on Thursday, October 22 at 9:30 a.m. ET. The call will be hosted by Chairman, CEO and President Tom Gentile and Chief Financial Officer Jamie Coogan.
The event will be webcast via the Investor Relations webpage at www.Hexcel.com. The event can also be accessed by dialing

Wells Fargo names 13 stocks as overweight tactical ideas

Thu, 01 Oct 2026 06:30:22 -0400

Investing.com -- Wells Fargo has released its list of overweight tactical ideas for the fourth quarter, naming 13 stocks across various sectors that the firm believes are positioned for gains.
The list includes Axsome Therapeutics (NASDAQ:AXSM), with Wells Fargo expecting fourth quarter Auvelity prescription data to show accelerated growth. The firm anticipates this will boost interest in the drug's commercial potential for Alzheimer's Disease Agitation treatment.
C.H. Robinson Worldwide (NASDAQ:CHRW) made the list as Wells Fargo sees improving brokerage margins and continuing market share gains. The firm expects potential third quarter earnings beats and moderate insurance costs to drive estimate revisions and

Wells Fargo names 13 stocks as overweight tactical ideas

Thu, 01 Oct 2026 06:30:22 -0400

Investing.com -- Wells Fargo has released its list of overweight tactical ideas for the fourth quarter, naming 13 stocks across various sectors that the firm believes are positioned for gains.
The list includes Axsome Therapeutics (NASDAQ:AXSM), with Wells Fargo expecting fourth quarter Auvelity prescription data to show accelerated growth. The firm anticipates this will boost interest in the drug's commercial potential for Alzheimer's Disease Agitation treatment.
C.H. Robinson Worldwide (NASDAQ:CHRW) made the list as Wells Fargo sees improving brokerage margins and continuing market share gains. The firm expects potential third quarter earnings beats and moderate insurance costs to drive estimate revisions and